A long-acting medicine developed by Novo Nordisk has been recommended as a treatment option for young people with growth ...

IntegriMedical has introduced a needle-free injection system (N-FIS) that eliminates the need for any prick or piercing, ...

New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal antibody, ...

Luton, Bedfordshire, United Kingdom, June 05, 2025 (GLOBE NEWSWIRE) -- The global pediatric glioma drugs market is poised for substantial growth, with an estimated value of approximately USD 5 billion ...